UK markets closed

Antibe Therapeutics Inc. (ATBPF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.21560.0000 (0.00%)
At close: 03:46PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CAD. All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
0
0
0
0
Cost of revenue
-
-
-
6,163
Gross profit
-
-
-
3,550
Operating expenses
Research development
10,753
11,308
14,358
13,427
Selling general and administrative
9,155
9,238
11,171
10,103
Total operating expenses
19,908
20,546
25,529
23,530
Operating income or loss
-19,908
-20,546
-25,529
-23,530
Interest expense
8
8
8
8
Total other income/expenses net
-17
-90
5
-360
Income before tax
-18,243
-19,291
-25,250
-23,853
Income tax expense
-7
-
0
0
Income from continuing operations
-18,243
-19,291
-25,250
-23,853
Net income
-18,555
-19,475
-25,060
-26,301
Net income available to common shareholders
-18,555
-19,475
-25,060
-26,301
Basic EPS
-0.36
-0.37
-0.50
-0.70
Diluted EPS
-0.36
-0.37
-0.50
-0.70
Basic average shares
52,532
52,286
50,774
37,252
Diluted average shares
52,532
52,286
50,774
37,252